Inhibitors of voltage-gated sodium channel Nav1.7: patent applications since 2010

Pharmaceutical patent analyst

Volumn 3, Issue 5, 2014, Pages 509-521

  Sun, Shaoyi ^a   Cohen, Charles J ^a   Dehnhardt, Christoph M ^a  

^a Xenon Pharmaceuticals Inc   (Canada)

Author keywords

analgesia; molecular selectivity; Nav1.7; pain; voltage sensor domain; voltage gated sodium channel

Indexed keywords

SCN9A PROTEIN, HUMAN; SODIUM CHANNEL NAV1.7; VOLTAGE GATED SODIUM CHANNEL BLOCKING AGENT;

CHEMICAL STRUCTURE; CHEMISTRY; DRUG APPROVAL; DRUG INDUSTRY; GENETICS; HUMAN; LEGISLATION AND JURISPRUDENCE; METABOLISM; PATENT; STATISTICS AND NUMERICAL DATA;

DRUG APPROVAL; DRUG INDUSTRY; HUMANS; MOLECULAR STRUCTURE; NAV1.7 VOLTAGE-GATED SODIUM CHANNEL; PATENTS AS TOPIC; VOLTAGE-GATED SODIUM CHANNEL BLOCKERS;

EID: 84933504937     PISSN: None     EISSN: 20468962     Source Type: Journal    
DOI: 10.4155/ppa.14.39     Document Type: Review

References (0)